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Abstract
Background: A minority of stroke patients is eligible for thrombolytic therapy. Small pilot case
series have hinted that elevation of incident arterial blood pressure might be associated with a
favorable prognosis either in acute or subacute stroke. However, these patients were not
considered for thrombolytic therapy and were not followed – up systematically. We used
pharmacologically induced hypertension in a stroke patient with middle cerebral artery (MCA)
occlusion ineligible for thrombolysis that was followed-up by radiological, clinical and functional
outcome assessment.
Case presentation: A patient with acute embolic MCA occlusion producing a large, ischemic
penumbra confirmed by perfusion CT was treated by induced hypertension with phenylephrine
started within 4 h of admission. Increase in the mean arterial pressure by 20% led to a reduction
of neurological deficit by 3 points on the National Institute of Stroke Scale. MRI and CT scans
performed during phenylephrine infusion showed the presence of limited subcortical and cortical
infarct changes that were clearly less extensive than the perfusion deficit in the brain perfusion CT
at baseline, found in the absence of MCA patency. No complications due to induced hypertension
therapy occurred. Moderate functional improvement up to modified Rankin scale 2 at follow up
took place.
Conclusion: Induced hypertension in acute ischemic stroke seems clinically feasible and may be
beneficial in selected normo- or hypotensive stroke patients not eligible for thrombolytic
recanalization therapy.
Background
Blood pressure (BP) increases after the first minutes of
acute cerebrovascular occlusion [1] and decreases signifi-
cantly from admission to 12 hours after thrombolysis
especially in case of adequate recanalization [2]. The
physiologic reasons for BP elevation, presumably may
represent increased sympathetic autonomic nervous activ-
ity mediated by cerebral reticular neuronal networks and
the medullary vasomotor center that regulate the tone of
resistance of vessels of the body. Due to the failure of
auto-regulation of cerebral blood flow (CBF) in the
ischemic human brain, the CBF is passively dependent on
the mean arterial pressure [3]. Thus, the acutely elevated
BP may help to maintain a vital level of CBF to support the
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neurological function. Therefore, hypertension may be a
risk marker of poor outcome due to initially large infarc-
tion or failed vessel recanalization [2] rather than a caus-
ative factor of the acute ischemic stroke [4].
Induced hypertension (IH) is a standard treatment for cer-
ebral ischemia in patients with vasospasm after subarach-
noidal hemorrhage. Elevation of BP may improve
neurological function and CBF in subacute ischemic
stroke [5], or alleviate the degree of neurologic dysfunc-
tion during acute ischemic stroke [6]. Phenylephrine-
induced hypertension (PHE-IH) decreased perfusion def-
icit by 40% as detected by MRI on the next day [7], sug-
gesting the efficacy of PHE-IH in precluding infarct
maturation within the ischemic penumbra.
We report a case where thrombolysis of acute embolic
MCA occlusion was not possible due to undocumented
onset time of stroke symptoms, but where a large area of
cerebral cortex corresponding to ischemic penumbra did
not undergo infarction following IH therapy.
Case presentation
A 72-year right-handed woman with paroxysmal atrial
fibrillation (AF), hypertension, coronary artery disease
(CAD), asthma and 2 recent transient ischemic attacks
was admitted to the emergency department with left
hemiparesis and dysarthria that were noticed on awaken-
ing 4 h 30 min prior to the admission. She had no antico-
agulant therapy. The baseline Barthel index of activities of
daily living was 95 and Rankin scale (mRS) was 1. Neuro-
logic examination revealed mild disorientation, left sen-
somotor hemiparesis, dysarthria, and visual and tactile
neglect. The National Institute of Health Stroke Scale
(NIHSS) score was 14. The mean BP was 150/72 mmHg,
the mean MAP (mean arterial pressure) was 98 mmHg
and ECG showed AF.
Immediate brain CT showed a hyperdense right MCA,
hypoattenuation of the right lentiform nucleus and insu-
lar cortex as well as slight swelling of cortical sulci in the
right frontoparietal region. Standard noncontrast CT scan-
ning was performed with a Lightspeed Ultra CT scanner
(General Electric Medical Systems; Version 05 MW
14.5.H2_P_M8_G) using the following parameters: 140
kV (posterior fossa/infratentorial)/120 kV (supratento-
rial), automatic mA (80–150 mA), 512 × 512 image
matrix, 23-cm displayed field of view (DFOV), and 5-mm
(posterior fossa/infratentorial)/7,5-mm (supratentorial)
slice thickness.
In CT perfusion examination, the flow- and mean transit
time images showed a broad perfusion deficit in the right
MCA region. The blood volume chart, however, showed a
clearly less significant defect in this region, consistent with
the presence of large ischemic penumbra in the cortical
cerebral tissue within the MCA territory (Fig 1, top row).
CT angiography documented a thrombus of 1 cm in
length in the right MCA. Some signs of blood flow were
detected distally in the right MCA, presumably resulting
from collateral circulation (not shown). For the perfusion
CT study, 4 adjacent levels were selected at the level of the
basal nuclei. Fifty 5-mm CT sections of continuous (cine)
scanning (80 kV, 200 mA) were obtained at every adjacent
level, with a total acquisition time of 50 seconds. Com-
puted tomography was initiated 5 seconds after the intra-
venous rapid infusion (injection rate of 7 ml/s) of 350
mg/ml iodinated nonionic contrast material (Iomeron
350, Bracco). The contrast agent was injected into an
antecubital vein with a power injector (Medrad).
A diagnosis of a cardio-embolic right MCA occlusion was
thus established. Due to the delay in admission and
uncertain timing of symptom onset the patient was not
eligible for thrombolysis. In attempt to salvage the obvi-
ously large ischemic penumbra, induced hypertension
(IH) therapy by phenylephrine (PHE) (Neo-Synephrine
0,1 mg/ml; initial dose 0.5 mg/hour)) and crystalloids
3000 ml/day intravenously was initiated 4 hours after the
admission. The goal of 20 % MAP augmentation was
achieved within 1 hour after the initiation of the PHE-
infusion (Figure 1). During the next 4 days the average
MAP was maintained at 120 (range 140-91) mmHg with
PHE infusion rate up to 3,5 mg/hour, thereafter PHE was
tapered off during 2 days (average MAP 114,5 (range 133-
99) mmHg). During PHE infusion the patient had parox-
ysmal AF with average heart rate 100 beats/min. The anti-
hypertensive medication (Athenolol and Lozartan) that
the patient had before the admission was stopped at the
time of initiation of IH.
Four hours after the initiation of MAP augmentation the
gaze deviation and the left leg weakness were improved
and NIHSS was 12. Sixteen hours after the MAP augmen-
tation the left facial weakness and hemiparesis were
improved, although the patient was still slightly somno-
lent, and had moderate dysarthria and neglect. The NIHSS
improved to 11. The brain CT and MRI scans performed
21 h and 26 h after admission showed the presence of a
limited subcortical infarct on the distal region of the right
lentiform nucleus and corona radiata. There were only
subtle signs of a cortical infarction. Moreover, the extent
of the subcortical infarct was substantially smaller than
that of the perfusion deficit found in the brain perfusion
CT on admission (Fig. 2, bottom row). MRA showed the
persistence of the right MCA occlusion (Fig. 2, middle
row).Page 2 of 5
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improvement on her level of alertness and in the left
hemiparesis, with less significant improvement in the
severity of dysarthria and neglect. Antithrombotic treat-
ment with sodium daltreparin followed by warfarin was
instituted. When discharged to the rehabilitation hospital,
the patient had a NIHSS of 7. At the 3-month control visit
she was independent in main activities of daily living, but
needed a walking device when strolling outside. The
uncontrasted control brain CT showed the previous right
MCA infarct without any new signs of ischemia (not
shown). NIHSS was 4; Barthel index was 80 and mRS 3. At
10-month interview she lived at home and walked inde-
pendently, Barthel index was 90 and mRS 2.
Conclusion
Many stroke patients are not eligible for thrombolysis due
to delay in the admission or unclear timing of symptom
onset. Still, there may be a therapeutic window for salvag-
ing of brain tissue through improvement of CBF in the
ischemic penumbra, which seems to exist well beyond the
sofar approved 3-hour window.
This case study suggests the potential utility of IH in the
treatment of acute stroke beyond the conventional throm-
bolytic treatment window. Studies have documented the
existence of an ischemic penumbra up to 24 hours after
stroke onset the and therapeutic time window for salvag-
ing brain tissue may be substantially longer [8].
Sparing of the ischemic penumbral brain tissue in the
present case was confirmed by the follow-up MRI and
supported by the relatively good functional outcome. The
spontaneous clot lysis or sudden improvement of collat-
erals to the occluded MCA territory seems unlikely
because the original vascular occlusion as well as collat-
eral flow remained essentially identical on the follow-up
MRA. A degree of functional improvement was achieved
already acutely upon increasing the average MAP by 20%.
Although we cannot confirm that it was PHE-IH that was
crucially responsible for the diversion toward a benign
outcome, our past experience of nonrecanalized acute
MCA occlusions in elderly patients attests of a much more
extensive infarct maturation in the MCA territory, espe-
Mean MAP on admission, during induced hypertension (days 1–5) and tapering off (days 6–7)Figure 1
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lowing the admission. In accordance with previous
reports of using IH [9] this study demonstrates relative
safety of PHE- IH, the patient was closely monitored, and
no evidence of cardiac ischemia were seen, the chest x ray
did not reveal any signs of pulmonary edema, and no
hemorrhagic transformation on CT scans was observed.
In conclusion, PHE-IH seems to be feasible and could be
beneficial in selected stroke patients within 6 hours from
stroke symptom onset. A prospective, randomized study
of PHE-IH could be warranted to examine whether PHE-
IH can salvage ischemic brain tissue in acute, documented
cerebrovascular occlusions that are not amenable for






Top row, left: Admission CT showing hypoattenuation of the right lentiform nucleus and insular cortex as well as slight swelling of cortical sulci in the right frontoparietal regionFigu e 2
Top row, left: Admission CT showing hypoattenuation of the right lentiform nucleus and insular cortex as well as slight swell-
ing of cortical sulci in the right frontoparietal region. Top row, the third and the fourth pictures: The perfusion CT on 
admission, with flow and mean transit time CT showing a broad perfusion deficit in the right MCA region. Top row, the sec-
ond picture: The volume chart shows only a small deficit in the right MCA region, consistent with the presence of a large 
ischemic penumbra in the cortical cerebral tissue. Middle row: The follow-up brain MRI showing the presence of a limited 
subcortical infarct on the distal region of the right lentiform nucleus and corona radiata. Signs of only a subtle cortical infarction 
are seen. From left to right: FLAIR MRI, T2-diffusion-weighted MRI, apparent diffusion coefficient. Middle row, right: The 
persistence of the right MCA occlusion on the follow up MRA. Bottom row: Day 2 CT showed that the extent of the subcor-
tical infarct was substantially smaller than that of the perfusion deficit found in the CT perfusion brain scan obtained on admis-
sion.Page 4 of 5
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